speb/financial-data huggingface dataset:
Financial ratios for 2692.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 745074187.9427884
Buffett classification: The Gruesome
Shares outstanding: 12686909
Book value: 772570511.9636412
Debt to equity: 0.03119593051422244
Current ratio: 1.42773120791535
Quick ratio: 1.27198021162567
Retained earnings: 597841197.7008421
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2692.T — annual report dated 2025-03-31
Total revenue: 4674301563.962037
Gross profit: 275130330.1697634
Operating income: 56850688.410640284
Net income: 54845608.87581874
Capital expenditures: 2152118.7007084615
Operating cash flow: -24929822.216281246
Depreciation & amortization: 11636144.900414383
Net tangible assets: 745074187.9427884
Owner earnings: 64329635.07552466
Return on net tangible assets (%): 8.633990563160445
Capex to operating income (%): 3.7855631319068896
Buffett classification: The Great
Shares outstanding: 12686909
Book value: 772570511.9636412
Debt to equity: 0.03119593051422244
Current ratio: 1.42773120791535
Quick ratio: 1.27198021162567
Effective tax rate (%): 27.219512195121954
Interest coverage ratio: 118.13888888888887
COGS to revenue (%): 94.11397988758438
Free cash flow (dilution-adjusted): -28946664.884373747
Retained earnings: 597841197.7008421
Inventory turnover: 29.036703723310392
Receivables turnover: 6.924308429536049
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.750204347239526
FCF margin (%): -0.6192725156533961
Revenue growth (%): 5.268075866704183
Rule of 40 score: 4.648803351050787
Financial ratios for 3317.HK — annual report dated 2022-12-31
Total revenue: 41364798.85057471
Gross profit: 32272126.436781608
Operating income: -16017816.091954023
Net income: -10796120.689655172
Capital expenditures: 308477.0114942529
Operating cash flow: -26575431.03448276
Depreciation & amortization: 2096695.4022988505
Net tangible assets: 155525143.6781609
Owner earnings: -9007902.298850574
Return on net tangible assets (%): -5.791926685173979
Buffett classification: The Gruesome
Shares outstanding: 274458506
Book value: 232250287.35632184
Debt to equity: 0.017517269196553956
Current ratio: 4.403295993017731
Quick ratio: 4.403295993017731
Interest coverage ratio: -118.60000000000001
COGS to revenue (%): 21.981667181893652
R&D to revenue (%): 89.88499439039387
SG&A to revenue (%): 15.615893073612622
Free cash flow (dilution-adjusted): -27630890.804597702
Retained earnings: -56776293.10344828
Receivables turnover: 3.756020874103066
Capitalized R&D asset: 37180747.126436785
ROCI (R&D-adjusted, %): 3.2458463026966533
FCF margin (%): -66.79807849280478
Rule of 40 score: -66.79807849280478
Financial ratios for 3317.HK — annual report dated 2023-12-31
Total revenue: 74607313.64275667
Gross profit: 58956118.143459916
Operating income: -9591139.240506329
Net income: -7773136.427566807
Capital expenditures: 543881.8565400844
Operating cash flow: -27282700.421940926
Depreciation & amortization: 2576652.6019690577
Net tangible assets: 175462728.55133614
Owner earnings: -5740365.682137834
Return on net tangible assets (%): -3.271558426984305
Buffett classification: The Gruesome
Shares outstanding: 274458506
Book value: 248583544.30379748
Debt to equity: 0.03273455397642564
Current ratio: 4.183771975674905
Quick ratio: 4.183771975674905
Interest coverage ratio: -50.17880794701987
COGS to revenue (%): 20.978098171768547
R&D to revenue (%): 71.47351910990126
SG&A to revenue (%): 11.149798853066596
Free cash flow (dilution-adjusted): -27842897.327707455
Retained earnings: -5040225.035161744
Receivables turnover: 1.9919714004611373
Capitalized R&D asset: 78235573.1485523
ROCI (R&D-adjusted, %): 4.143361107679762
Rosenberg metric: 0.7176830421383619
FCF margin (%): -37.31925996026076
Revenue growth (%): 80.36426071420411
Rule of 40 score: 43.04500075394335
Financial ratios for 3317.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 157413698.630137
Buffett classification: The Gruesome
Shares outstanding: 274458506
Book value: 225940000
Debt to equity: 0.0325938150630365
Current ratio: 5.497558108533895
Quick ratio: 5.497558108533895
Retained earnings: -16417397.260273973
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3317.HK — annual report dated 2024-12-31
Total revenue: 86572328.7671233
Gross profit: 66387260.2739726
Operating income: -12441780.821917808
Net income: -11508356.164383562
Capital expenditures: 2677808.2191780824
Operating cash flow: -23318219.178082194
Depreciation & amortization: 3256438.3561643837
Net tangible assets: 157413698.630137
Owner earnings: -10929726.02739726
Return on net tangible assets (%): -6.943313143971038
Buffett classification: The Gruesome
Shares outstanding: 274458506
Book value: 225940000
Debt to equity: 0.0325938150630365
Current ratio: 5.497558108533895
Quick ratio: 5.497558108533895
Interest coverage ratio: -41.49154865235267
COGS to revenue (%): 23.315843273025326
R&D to revenue (%): 71.27479121108647
SG&A to revenue (%): 20.92098142656865
Free cash flow (dilution-adjusted): -26039041.09589041
Retained earnings: -16417397.260273973
Receivables turnover: 2.510549042819858
Capitalized R&D asset: 109701289.75153917
ROCI (R&D-adjusted, %): -0.4359697719239699
Rosenberg metric: 0.13935706762448719
FCF margin (%): -30.077787517919923
Revenue growth (%): 16.037321999903238
Rule of 40 score: -14.040465518016685
Financial ratios for 3317.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 148503626.22036263
Buffett classification: The Gruesome
Shares outstanding: 274458506
Book value: 215269874.47698742
Debt to equity: 0.04940054487086043
Current ratio: 4.256679961149801
Quick ratio: 4.256679961149801
Retained earnings: -29187726.638772663
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9690.HK — annual report dated 2022-12-31
Total revenue: 1659030316.091954
Gross profit: 326175574.7126437
Operating income: -116127873.56321838
Net income: -306921408.045977
Capital expenditures: 55942528.73563218
Operating cash flow: -44929741.37931035
Depreciation & amortization: 52266666.666666664
Net tangible assets: -2735999137.9310346
Owner earnings: -310597270.11494255
Buffett classification: The Gruesome
Shares outstanding: 755435235
Book value: -2723644252.873563
Debt to equity: -0.017953148049403893
Current ratio: 1.2393394421125303
Quick ratio: 0.9625103123560375
Interest coverage ratio: -28.99551569506726
COGS to revenue (%): 80.33938430486373
R&D to revenue (%): 5.381250697701044
SG&A to revenue (%): 16.812462549313228
Free cash flow (dilution-adjusted): -134007758.62068966
Retained earnings: -2700687931.034483
Inventory turnover: 6.013864731512233
Receivables turnover: 66.46396440474065
Capitalized R&D asset: 89276580.45977011
ROCI (R&D-adjusted, %): -9.696759089491366
FCF margin (%): -8.077474975644876
Rule of 40 score: -8.077474975644876
Financial ratios for ALTAI.PA — annual report dated 2022-12-31
Total revenue: 1963829.7872340428
Gross profit: 591489.3617021277
Operating income: -368085.10638297873
Net income: -141489.36170212767
Capital expenditures: 8510.638297872341
Operating cash flow: -442553.19148936175
Depreciation & amortization: 629787.2340425532
Net tangible assets: -645744.6808510639
Owner earnings: 479787.23404255323
Buffett classification: The Gruesome
Shares outstanding: 7276384
Book value: 787234.0425531915
Debt to equity: 2.4716216216216216
Current ratio: 3.1899313501144166
Quick ratio: 3.1899313501144166
Interest coverage ratio: -10.484848484848484
COGS to revenue (%): 69.88082340195015
Free cash flow (dilution-adjusted): -451063.8297872341
Receivables turnover: 4.057142857142858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.473520249221183
FCF margin (%): -22.968580715059588
Rule of 40 score: -22.968580715059588
Financial ratios for ALTAI.PA — annual report dated 2023-12-31
Total revenue: 8851111.11111111
Gross profit: 6558888.888888889
Operating income: 4085555.5555555555
Net income: 4264444.444444444
Capital expenditures: 31111.11111111111
Operating cash flow: 4412222.222222222
Depreciation & amortization: 688888.8888888889
Net tangible assets: 3831111.111111111
Owner earnings: 4922222.222222222
Return on net tangible assets (%): 128.48027842227378
Capex to operating income (%): 0.7614903453902638
Buffett classification: The Great
Shares outstanding: 7276384
Book value: 4870000
Debt to equity: 0.4010951403148528
Current ratio: 5.957528957528958
Quick ratio: 5.957528957528958
Effective tax rate (%): -5.352731265440571
Interest coverage ratio: 102.13888888888889
COGS to revenue (%): 25.897564649761488
Free cash flow (dilution-adjusted): 4381111.111111111
Receivables turnover: 10.838095238095237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 59.87624165445368
FCF margin (%): 49.49786593020337
Revenue growth (%): 350.70663296015397
Rule of 40 score: 400.20449889035734
Financial ratios for BAC.DE — annual report dated 2022-12-31
Total revenue: 136835000000
Gross profit: 77702000000
Operating income: 30467000000
Net income: 21748000000
Capital expenditures: 26740000000
Operating cash flow: 37141000000
Depreciation & amortization: 17099000000
Net tangible assets: -98784000000
Owner earnings: 12107000000
Return on net tangible assets (%): -12.256033365727244
Capex to operating income (%): 87.76709226376079
Buffett classification: The Gruesome
Shares outstanding: 4175558910
Book value: 92463000000
Debt to equity: 1.9070438986405374
Current ratio: 0.7545594068286461
Quick ratio: 0.7069621893125511
Effective tax rate (%): 23.07311379151781
Interest coverage ratio: 8.43260448380847
COGS to revenue (%): 43.214820769539955
SG&A to revenue (%): 22.023605071801803
Free cash flow (dilution-adjusted): 10401000000
Retained earnings: 82380000000
Inventory turnover: 24.762562814070353
Receivables turnover: 5.583734595609238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.246181439657187
FCF margin (%): 7.601125443051851
Rule of 40 score: 7.601125443051851
Financial ratios for BAC.DE — annual report dated 2023-12-31
Total revenue: 133974000000
Gross profit: 79087000000
Operating income: 28718000000
Net income: 12095000000
Capital expenditures: 24563000000
Operating cash flow: 37475000000
Depreciation & amortization: 17624000000
Net tangible assets: -97137000000
Owner earnings: 5156000000
Return on net tangible assets (%): -5.307967098016204
Capex to operating income (%): 85.53172226478168
Buffett classification: The Gruesome
Shares outstanding: 4175558910
Book value: 93799000000
Debt to equity: 1.8650731884135225
Current ratio: 0.6916934408056667
Quick ratio: 0.6530447362982169
Effective tax rate (%): 28.798492965208688
Interest coverage ratio: 5.198769007965242
COGS to revenue (%): 40.96839685312075
SG&A to revenue (%): 24.44130950781495
Free cash flow (dilution-adjusted): 12912000000
Retained earnings: 82915000000
Inventory turnover: 26.68303354399611
Receivables turnover: 5.340801275662747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.781403654688226
FCF margin (%): 9.637690895248332
Revenue growth (%): -2.0908393320422407
Rule of 40 score: 7.546851563206091
Financial ratios for BAC.DE — annual report dated 2024-12-31
Total revenue: 134788000000
Gross profit: 80691000000
Operating income: 28686000000
Net income: 17949000000
Capital expenditures: 17990000000
Operating cash flow: 36912000000
Depreciation & amortization: 17892000000
Net tangible assets: -91346000000
Owner earnings: 17851000000
Return on net tangible assets (%): -19.54218028156679
Capex to operating income (%): 62.71351878965349
Buffett classification: The Good
Shares outstanding: 4175558910
Book value: 100575000000
Debt to equity: 1.673944817300522
Current ratio: 0.6256349292121474
Quick ratio: 0.5909434777909867
Effective tax rate (%): 21.889551329474738
Interest coverage ratio: 4.314332982403369
COGS to revenue (%): 40.134878475828714
SG&A to revenue (%): 25.30863281597768
Free cash flow (dilution-adjusted): 18922000000
Retained earnings: 89110000000
Inventory turnover: 24.075211392968402
Receivables turnover: 5.162511011528592
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.96605613552541
FCF margin (%): 14.038341692138767
Revenue growth (%): 0.6075805753355128
Rule of 40 score: 14.64592226747428
Financial ratios for BAC.DE — quarterly report dated 2025-03-31
Total revenue: 33485000000
Gross profit: 20429000000
Operating income: 7978000000
Net income: 4983000000
Capital expenditures: 4267000000
Operating cash flow: 7782000000
Depreciation & amortization: 4577000000
Net tangible assets: -89693000000
Owner earnings: 5293000000
Return on net tangible assets (%): -5.901240899512782
Capex to operating income (%): 53.484582602155925
Buffett classification: The Good
Shares outstanding: 4175558910
Book value: 102037000000
Debt to equity: 1.643658672834364
Current ratio: 0.6116824419480562
Quick ratio: 0.5757049749451413
Effective tax rate (%): 23.01869303259694
Interest coverage ratio: 4.888480392156863
COGS to revenue (%): 38.9905928027475
SG&A to revenue (%): 23.51500671942661
Free cash flow (dilution-adjusted): 3515000000
Retained earnings: 91128000000
Inventory turnover: 5.942649066909422
Receivables turnover: 1.2934064660666693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4986063176092554
FCF margin (%): 10.497237569060774
Rule of 40 score: 10.497237569060774
Financial ratios for BAC.DE — quarterly report dated 2025-06-30
Total revenue: 34504000000
Gross profit: 20619000000
Operating income: 8172000000
Net income: 5121000000
Capital expenditures: 3920000000
Operating cash flow: 8975000000
Depreciation & amortization: 4635000000
Net tangible assets: -87233000000
Owner earnings: 5836000000
Return on net tangible assets (%): -6.69012873568489
Capex to operating income (%): 47.96867351933432
Buffett classification: The Good
Shares outstanding: 4175558910
Book value: 104361000000
Debt to equity: 1.6279165588677762
Current ratio: 0.6373211707573172
Quick ratio: 0.6022607953799711
Effective tax rate (%): 22.514752610077167
Interest coverage ratio: 4.985967053081147
COGS to revenue (%): 40.24171110595873
SG&A to revenue (%): 22.640853234407604
Free cash flow (dilution-adjusted): 5055000000
Retained earnings: 93275000000
Inventory turnover: 6.497426298549368
Receivables turnover: 1.3131874405328259
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5352663239569018
FCF margin (%): 14.650475307210758
Revenue growth (%): 3.0431536508884576
Rule of 40 score: 17.693628958099215
Financial ratios for BAC.DE — quarterly report dated 2025-09-30
Total revenue: 33821000000
Gross profit: 20475000000
Operating income: 8105000000
Net income: 5056000000
Capital expenditures: 4416000000
Operating cash flow: 11266000000
Depreciation & amortization: 4618000000
Net tangible assets: -85241000000
Owner earnings: 5258000000
Return on net tangible assets (%): -6.168393144144249
Capex to operating income (%): 54.48488587291796
Buffett classification: The Good
Shares outstanding: 4175558910
Book value: 106345000000
Debt to equity: 1.6028210070995346
Current ratio: 0.7388815204069641
Quick ratio: 0.6935513657807699
Effective tax rate (%): 22.537153362953884
Interest coverage ratio: 4.870793269230769
COGS to revenue (%): 39.46069010378167
SG&A to revenue (%): 22.92067058927885
Free cash flow (dilution-adjusted): 6850000000
Retained earnings: 95316000000
Inventory turnover: 4.942962962962963
Receivables turnover: 1.3048225308641976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4652642592953087
FCF margin (%): 20.253688536707962
Revenue growth (%): -1.9794806399258058
Rule of 40 score: 18.274207896782155
Financial ratios for BAC.DE — quarterly report dated 2025-12-31
Total revenue: 36381000000
Gross profit: 19903000000
Operating income: 5004000000
Net income: 2448000000
Capital expenditures: 4858000000
Operating cash flow: 9114000000
Depreciation & amortization: 4519000000
Net tangible assets: -85878000000
Owner earnings: 2109000000
Return on net tangible assets (%): -2.455809404038287
Capex to operating income (%): 97.08233413269384
Buffett classification: The Gruesome
Shares outstanding: 4175558910
Book value: 105741000000
Debt to equity: 1.717810499238706
Current ratio: 0.9126503126503126
Quick ratio: 0.8735129068462402
Effective tax rate (%): 20.078354554358473
Interest coverage ratio: 2.8447981807845366
COGS to revenue (%): 45.292872653308045
SG&A to revenue (%): 28.53137626783211
Free cash flow (dilution-adjusted): 4256000000
Retained earnings: 94744000000
Inventory turnover: 6.750512085210979
Receivables turnover: 1.34262095434919
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4636372145263947
FCF margin (%): 11.69841400731151
Revenue growth (%): 7.569261701309838
Rule of 40 score: 19.267675708621347
Financial ratios for BAC.DE — annual report dated 2025-12-31
Total revenue: 138191000000
Gross profit: 81426000000
Operating income: 29259000000
Net income: 17608000000
Capital expenditures: 17461000000
Operating cash flow: 37137000000
Depreciation & amortization: 18349000000
Net tangible assets: -85878000000
Owner earnings: 18496000000
Return on net tangible assets (%): -21.53752998439647
Capex to operating income (%): 59.677364229809626
Buffett classification: The Good
Shares outstanding: 4175558910
Book value: 105741000000
Debt to equity: 1.717810499238706
Current ratio: 0.9126503126503126
Quick ratio: 0.8735129068462402
Effective tax rate (%): 22.33592095977417
Interest coverage ratio: 4.370929190319689
COGS to revenue (%): 41.07720473836936
SG&A to revenue (%): 24.471926536460405
Free cash flow (dilution-adjusted): 19676000000
Retained earnings: 94744000000
Inventory turnover: 23.254813600983205
Receivables turnover: 5.099863453518839
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.558065799326094
FCF margin (%): 14.238264431113459
Revenue growth (%): 2.5247054633943673
Rule of 40 score: 16.762969894507826
Financial ratios for IOTR — annual report dated 2022-03-31
Total revenue: 2877114.814814815
Gross profit: 760786.6666666666
Operating income: 201391.85185185182
Net income: 177375.55555555553
Capital expenditures: 64497.03703703703
Operating cash flow: 139965.92592592593
Depreciation & amortization: 64763.7037037037
Net tangible assets: 766225.1851851852
Owner earnings: 177642.22222222222
Return on net tangible assets (%): 23.184075080916163
Capex to operating income (%): 32.025643760643526
Buffett classification: The Good
Shares outstanding: 3032199
Book value: 1057349.6296296294
Debt to equity: 0.40136063476673334
Current ratio: 1.9741628876832134
Quick ratio: 1.5913164358787486
Effective tax rate (%): 10.57830191497625
Interest coverage ratio: 21.60341676599126
COGS to revenue (%): 73.55730599455987
SG&A to revenue (%): 21.399164028778827
Free cash flow (dilution-adjusted): -215655.55555555553
Retained earnings: 462803.70370370365
Inventory turnover: 6.294904222832289
Receivables turnover: 2.319196805756994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.323402881067343
FCF margin (%): -7.495549167697576
Rule of 40 score: -7.495549167697576
Financial ratios for IOTR — annual report dated 2023-03-31
Total revenue: 5629747.368421053
Gross profit: 1696036.0902255639
Operating income: 789003.007518797
Net income: 694857.1428571428
Capital expenditures: 5397.744360902256
Operating cash flow: 545828.5714285714
Depreciation & amortization: 184347.3684210526
Net tangible assets: 1373063.1578947369
Owner earnings: 873806.7669172932
Return on net tangible assets (%): 63.63922605403428
Capex to operating income (%): 0.6841221528263518
Buffett classification: The Great
Shares outstanding: 3032199
Book value: 1708978.947368421
Debt to equity: 0.42179958837489034
Current ratio: 1.716791728783857
Quick ratio: 1.1952436782363536
Effective tax rate (%): 11.098541364247213
Interest coverage ratio: 43.81336896162999
COGS to revenue (%): 69.87367319998867
SG&A to revenue (%): 16.056597312557194
Free cash flow (dilution-adjusted): 456218.0451127819
Retained earnings: 1105492.4812030075
Inventory turnover: 4.448208460193153
Receivables turnover: 3.2641181986493755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.697527147633984
FCF margin (%): 8.103703687874988
Revenue growth (%): 95.67336483870598
Rule of 40 score: 103.77706852658096
Financial ratios for IOTR — annual report dated 2024-03-31
Total revenue: 6348200
Gross profit: 1367104.4444444443
Operating income: -24554.814814814814
Net income: -3293.333333333333
Capital expenditures: 346929.6296296296
Operating cash flow: 1208459.259259259
Depreciation & amortization: 274360.74074074073
Net tangible assets: 1160163.7037037036
Owner earnings: -75862.22222222219
Return on net tangible assets (%): -6.53892394496051
Buffett classification: The Gruesome
Shares outstanding: 3032199
Book value: 1463700.7407407411
Debt to equity: 0.42778730321316427
Current ratio: 1.2650118981534042
Quick ratio: 1.0047324470145647
Interest coverage ratio: -0.9251744348311471
COGS to revenue (%): 78.4646916536271
SG&A to revenue (%): 21.705213609690468
Free cash flow (dilution-adjusted): 844485.1851851852
Retained earnings: 869154.8148148147
Inventory turnover: 7.36984125940344
Receivables turnover: 3.391288140797853
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4121791881535253
FCF margin (%): 13.302750152565848
Revenue growth (%): 12.761720634374546
Rule of 40 score: 26.064470786940394
Financial ratios for IOTR — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1277013.28125
Buffett classification: The Gruesome
Shares outstanding: 3032199
Book value: 1568350.78125
Debt to equity: 0.391537388249699
Current ratio: 1.2985446257989324
Quick ratio: 1.026195471696105
Retained earnings: 941290.625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IOTR — annual report dated 2025-03-31
Total revenue: 7819813.43283582
Gross profit: 1391219.4029850746
Operating income: -151234.32835820894
Net income: -172026.11940298506
Capital expenditures: 409506.7164179104
Operating cash flow: 364251.49253731343
Depreciation & amortization: 410154.4776119403
Net tangible assets: 1028016.4179104477
Owner earnings: -171378.35820895518
Return on net tangible assets (%): -16.670780273850085
Buffett classification: The Gruesome
Shares outstanding: 3032199
Book value: 1302597.7611940303
Debt to equity: 0.41481517129089324
Current ratio: 1.1258933622317187
Quick ratio: 0.9376391927535935
Interest coverage ratio: -5.83983632067316
COGS to revenue (%): 82.20904609893545
SG&A to revenue (%): 19.602616774267435
Free cash flow (dilution-adjusted): -69367.91044776118
Retained earnings: 703614.9253731343
Inventory turnover: 12.47509634029957
Receivables turnover: 3.497318407151537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.140406709098912
FCF margin (%): -0.8870788420153551
Revenue growth (%): 23.18158584852116
Rule of 40 score: 22.294507006505803
Financial ratios for IOTR — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1028016.4179104477
Buffett classification: The Gruesome
Shares outstanding: 3032199
Book value: 1302597.7611940303
Debt to equity: 0.41481517129089324
Current ratio: 1.1258933622317187
Quick ratio: 0.9376391927535935
Retained earnings: 703614.9253731343
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MMTX.SW — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -2222.222222222222
Net income: -1111.111111111111
Capital expenditures: 0
Operating cash flow: -3333.333333333333
Depreciation & amortization: 0
Net tangible assets: 95555.55555555555
Owner earnings: -1111.111111111111
Return on net tangible assets (%): -1.1627906976744187
Buffett classification: The Gruesome
Shares outstanding: 157602044
Book value: 95555.55555555555
Debt to equity: 0
Current ratio: 0
Quick ratio: 0
Free cash flow (dilution-adjusted): -3333.333333333333
Retained earnings: -15555.555555555555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1978021978021975
Rule of 40 score: 0
Financial ratios for QMMM — annual report dated 2021-09-30
Total revenue: 457862.7249357326
Gross profit: 204590.10282776348
Operating income: 149942.6735218509
Net income: 137052.5706940874
Capital expenditures: 5355.012853470437
Operating cash flow: 14751.41388174807
Depreciation & amortization: 24723.264781491
Net tangible assets: -57496.65809768638
Owner earnings: 156420.82262210795
Return on net tangible assets (%): -272.0520249304754
Capex to operating income (%): 3.5713734640659585
Buffett classification: The Great
Shares outstanding: 48951842
Book value: -54863.88174807199
Debt to equity: -2.604726350092891
Current ratio: 0.5864284074226115
Quick ratio: 0.5864284074226115
Effective tax rate (%): 7.311745142048467
Interest coverage ratio: 41.146837854043945
COGS to revenue (%): 55.31627894441931
SG&A to revenue (%): 11.935330466917375
Free cash flow (dilution-adjusted): 6581.748071979434
Retained earnings: -56925.8354755784
Receivables turnover: 6.117175519428221
Capitalized R&D asset: 0
FCF margin (%): 1.4374937538108772
Rule of 40 score: 1.4374937538108772
Financial ratios for QMMM — annual report dated 2022-09-30
Total revenue: 432611.46496815287
Gross profit: 170541.1464968153
Operating income: 118320.25477707006
Net income: 101982.54777070064
Capital expenditures: 4620.254777070064
Operating cash flow: 81297.5796178344
Depreciation & amortization: 26149.936305732484
Net tangible assets: 45846.11464968153
Owner earnings: 123512.22929936305
Return on net tangible assets (%): 269.40609960766005
Capex to operating income (%): 3.904872234914633
Buffett classification: The Great
Shares outstanding: 48951842
Book value: 47742.92993630572
Debt to equity: 0.9548297410227815
Current ratio: 1.1822510340671584
Quick ratio: 1.1822510340671584
Effective tax rate (%): 12.690079079877108
Interest coverage ratio: 30.836094419175986
COGS to revenue (%): 60.57868080094229
SG&A to revenue (%): 13.778680800942286
Free cash flow (dilution-adjusted): 76677.32484076434
Retained earnings: 45564.331210191085
Receivables turnover: 7.325343618150286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 247.8278038966653
FCF margin (%): 17.724293286219083
Revenue growth (%): -5.515028542916243
Rule of 40 score: 12.20926474330284
Financial ratios for QMMM — annual report dated 2023-09-30
Total revenue: 358609.06768837804
Gross profit: 80519.28480204342
Operating income: -163581.99233716476
Net income: -164907.9182630907
Capital expenditures: 1575.3512132822477
Operating cash flow: -144814.8148148148
Depreciation & amortization: 26129.629629629628
Net tangible assets: -120066.41123882504
Owner earnings: -140353.6398467433
Buffett classification: The Gruesome
Shares outstanding: 48951842
Book value: -116933.0779054917
Debt to equity: -0.3550829741826546
Current ratio: 0.36074679374206997
Quick ratio: 0.36074679374206997
Interest coverage ratio: -144.7775517124449
COGS to revenue (%): 77.54677947184186
SG&A to revenue (%): 68.90661342657472
Free cash flow (dilution-adjusted): -148950.31928480204
Retained earnings: -119227.2030651341
Receivables turnover: 5.406406259927952
Capitalized R&D asset: 0
FCF margin (%): -41.53556970685303
Revenue growth (%): -17.10597228051332
Rule of 40 score: -58.64154198736635
Financial ratios for RNA — annual report dated 2023-12-31
Total revenue: 9764000
Operating income: -6386000
Net income: -6385000
Capital expenditures: 320000
Operating cash flow: 56390000
Depreciation & amortization: 138000
Net tangible assets: -70619000
Owner earnings: -6567000
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: -70619000
Debt to equity: -0.13950919724153557
Current ratio: 0.025324694535664626
Quick ratio: 0.025324694535664626
COGS to revenue (%): 0
R&D to revenue (%): 129.5882834903728
SG&A to revenue (%): 35.81523965587874
Free cash flow (dilution-adjusted): 53563000
Receivables turnover: 13.00133155792277
Capitalized R&D asset: 12653000
FCF margin (%): 548.576403113478
Rule of 40 score: 548.576403113478
Financial ratios for RNA — quarterly report dated 2024-12-31
Total revenue: 2973000
Operating income: -44249000
Net income: -46195000
Capital expenditures: 218000
Operating cash flow: -8263000
Depreciation & amortization: 58000
Net tangible assets: -61108000
Owner earnings: -46355000
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: -61108000
Debt to equity: -0.11129475682398376
Current ratio: 0.018021043205730915
Quick ratio: 0.018021043205730915
COGS to revenue (%): 0
R&D to revenue (%): 721.3252606794483
SG&A to revenue (%): 867.0366633030609
Free cash flow (dilution-adjusted): -9571000
Capitalized R&D asset: 21445000
ROCI (R&D-adjusted, %): -1637.6344086021504
FCF margin (%): -321.93070972082074
Rule of 40 score: -321.93070972082074
Financial ratios for RNA — annual report dated 2024-12-31
Total revenue: 10897000
Operating income: -13218000
Net income: -25122000
Capital expenditures: 266000
Operating cash flow: -22553000
Depreciation & amortization: 172000
Net tangible assets: -61108000
Owner earnings: -25216000
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: -61108000
Debt to equity: -0.11129475682398376
Current ratio: 0.018021043205730915
Quick ratio: 0.018021043205730915
COGS to revenue (%): 0
R&D to revenue (%): 176.18610626778013
SG&A to revenue (%): 45.11333394512251
Free cash flow (dilution-adjusted): -25996000
Capitalized R&D asset: 27676510
ROCI (R&D-adjusted, %): -57.51910652469054
FCF margin (%): -238.5610718546389
Revenue growth (%): 11.603850880786563
Rule of 40 score: -226.95722097385234
Financial ratios for RNA — quarterly report dated 2025-03-31
Total revenue: 1573000
Operating income: -7452000
Net income: -7449000
Capital expenditures: 0
Operating cash flow: -11103000
Depreciation & amortization: 53000
Owner earnings: -7396000
Buffett classification: The Gruesome
Shares outstanding: 17105643
COGS to revenue (%): 0
R&D to revenue (%): 441.0044500953592
SG&A to revenue (%): 132.73998728544183
Free cash flow (dilution-adjusted): -12313000
Capitalized R&D asset: 21305150
ROCI (R&D-adjusted, %): -46.822794801569884
FCF margin (%): -782.7717736808646
Revenue growth (%): -47.09048099562732
Rule of 40 score: -829.862254676492
Financial ratios for RNA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 212853000
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: 212853000
Debt to equity: 0.02010307583167726
Current ratio: 8.546646082107186
Quick ratio: 8.546646082107186
Capitalized R&D asset: 11724640
Rule of 40 score: 0
Financial ratios for RNA — quarterly report dated 2025-12-31
Total revenue: 859000
Operating income: -48035000
Net income: -48069000
Capital expenditures: 879000
Operating cash flow: -19252000
Depreciation & amortization: 122000
Net tangible assets: 207287000
Owner earnings: -48826000
Return on net tangible assets (%): -23.554781534780282
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: 207287000
Debt to equity: 0.01771456965463343
Current ratio: 6.527236190521758
Quick ratio: 6.527236190521758
COGS to revenue (%): 0
R&D to revenue (%): 2153.317811408615
SG&A to revenue (%): 3538.6495925494764
Free cash flow (dilution-adjusted): -23683000
Capitalized R&D asset: 20786210
ROCI (R&D-adjusted, %): -14.772777039212325
FCF margin (%): -2757.0430733410944
Rule of 40 score: -2757.0430733410944
Financial ratios for RNA — annual report dated 2025-12-31
Total revenue: 18618000
Operating income: -76814000
Net income: -76684000
Capital expenditures: 1445000
Operating cash flow: -41129000
Depreciation & amortization: 323000
Net tangible assets: 207287000
Owner earnings: -77806000
Return on net tangible assets (%): -37.535397781819405
Buffett classification: The Gruesome
Shares outstanding: 17105643
Book value: 207287000
Debt to equity: 0.01771456965463343
Current ratio: 6.527236190521758
Quick ratio: 6.527236190521758
COGS to revenue (%): 0
R&D to revenue (%): 288.73133526694596
SG&A to revenue (%): 223.8478891395424
Free cash flow (dilution-adjusted): -50253000
Capitalized R&D asset: 70794820
ROCI (R&D-adjusted, %): -16.786898917646194
FCF margin (%): -269.91621011923945
Revenue growth (%): 70.85436358630815
Rule of 40 score: -199.0618465329313
Financial ratios for SRQ.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -363.9705882352941
Operating income: -408847.79411764705
Net income: -408785.29411764705
Capital expenditures: 8167.647058823529
Operating cash flow: -446147.79411764705
Depreciation & amortization: 363.9705882352941
Net tangible assets: -632383.8235294117
Owner earnings: -416588.9705882353
Buffett classification: The Gruesome
Shares outstanding: 46095650
Book value: -632383.8235294117
Debt to equity: 0
Current ratio: 0.2707129239666154
Quick ratio: 0.2707129239666154
Free cash flow (dilution-adjusted): -454315.44117647054
Retained earnings: -632384.5588235294
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UYFINCORP.NS — annual report dated 2022-03-31
Total revenue: 11042568.904127654
Gross profit: 2536885.1378082554
Operating income: 413675.3263879731
Net income: 423737.3071343795
Capital expenditures: 580.2452855070553
Operating cash flow: -660833.4432282738
Depreciation & amortization: 21706.44863510484
Net tangible assets: 32341764.473163657
Owner earnings: 444863.51048397727
Return on net tangible assets (%): 1.3755078541033632
Capex to operating income (%): 0.14026586757626958
Buffett classification: The Great
Shares outstanding: 190238329
Book value: 32341764.473163657
Debt to equity: 0.05708516617491873
Current ratio: 166.31239355430367
Quick ratio: 154.95015066160093
Effective tax rate (%): 24.445071482317534
COGS to revenue (%): 77.0263137152807
SG&A to revenue (%): 0.09840474444622253
Free cash flow (dilution-adjusted): -661413.6885137808
Retained earnings: 5813332.45417381
Inventory turnover: 3.7184415644313256
Receivables turnover: 7.596944376400569
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0384503721094522
FCF margin (%): -5.989672278762489
Rule of 40 score: -5.989672278762489
Financial ratios for UYFINCORP.NS — annual report dated 2023-03-31
Total revenue: 6582533.495736906
Gross profit: 1460986.6017052375
Operating income: 1205895.2496954934
Net income: 943410.4750304507
Capital expenditures: 3495.736906211937
Operating cash flow: -401948.8428745433
Depreciation & amortization: 24847.74665042631
Net tangible assets: 30816479.902557857
Owner earnings: 964762.4847746651
Return on net tangible assets (%): 3.13067062761632
Capex to operating income (%): 0.28988727728172603
Buffett classification: The Great
Shares outstanding: 190238329
Book value: 30816479.90255786
Debt to equity: 0.003952517615382882
Current ratio: 264.22346083043567
Quick ratio: 249.050623849458
Effective tax rate (%): 30.2756422951587
COGS to revenue (%): 77.80510190109284
SG&A to revenue (%): 0.5804680011694479
Free cash flow (dilution-adjusted): -401948.8428745433
Retained earnings: 6125103.532277711
Inventory turnover: 2.8341803720679426
Receivables turnover: 3.0098913951545527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.370807939804569
FCF margin (%): -6.106293923682428
Revenue growth (%): -40.38947320241407
Rule of 40 score: -46.495767126096496
Financial ratios for UYFINCORP.NS — annual report dated 2024-03-31
Total revenue: 23437054.80273414
Gross profit: 11523120.278210817
Operating income: 14205672.1429428
Net income: 7785381.940280609
Capital expenditures: 3069.912459527521
Operating cash flow: -2214666.0271015707
Depreciation & amortization: 19858.496222568654
Net tangible assets: 38133864.97181916
Owner earnings: 7802170.52404365
Return on net tangible assets (%): 20.459952144398258
Capex to operating income (%): 0.021610469597192664
Buffett classification: The Great
Shares outstanding: 190238329
Book value: 38133864.97181916
Debt to equity: 0.0031446708991840523
Current ratio: 199.84593175853018
Quick ratio: 190.84317585301838
Effective tax rate (%): 23.056237355750376
COGS to revenue (%): 50.833752896005755
SG&A to revenue (%): 0.16229912157902923
Free cash flow (dilution-adjusted): -2214666.0271015707
Retained earnings: 12265187.67238278
Inventory turnover: 7.241169953790761
Receivables turnover: 2.8467910501024716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.37884874880156
FCF margin (%): -9.449421208176764
Revenue growth (%): 256.04915368699375
Rule of 40 score: 246.59973247881697
Financial ratios for UYFINCORP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 39009173.43526039
Buffett classification: The Gruesome
Shares outstanding: 190238329
Book value: 39009173.43526039
Debt to equity: 0.012597034522121053
Current ratio: 179.82535529523696
Quick ratio: 169.55949336980436
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WAAREERTL.NS — annual report dated 2023-03-31
Total revenue: 42729573.6906212
Gross profit: 11890852.618757613
Operating income: 9879683.313032888
Net income: 6750669.914738125
Capital expenditures: 10145091.352009745
Operating cash flow: 7935200.974421438
Depreciation & amortization: 359841.6565164434
Net tangible assets: 9993191.230207065
Owner earnings: -3034579.780755177
Return on net tangible assets (%): -30.366473640395842
Capex to operating income (%): 102.68640229213362
Buffett classification: The Gruesome
Shares outstanding: 104345792
Book value: 10353264.31181486
Debt to equity: 0.45862544014550544
Current ratio: 0.8420343154243812
Quick ratio: 0.6009562795536658
Effective tax rate (%): 28.152600429531176
Interest coverage ratio: 15.651474220438407
COGS to revenue (%): 72.17184354598987
SG&A to revenue (%): 0.4979336381138726
Free cash flow (dilution-adjusted): -2312070.645554202
Retained earnings: 1118148.599269184
Inventory turnover: 6.932953076737717
Receivables turnover: 5.721873812393676
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 61.825962083747484
FCF margin (%): -5.410937778819177
Rule of 40 score: -5.410937778819177
Financial ratios for WAAREERTL.NS — annual report dated 2024-03-31
Total revenue: 105096534.3566375
Gross profit: 27659899.268497422
Operating income: 24133025.54263101
Net income: 17425002.997961387
Capital expenditures: 1292517.0883799016
Operating cash flow: 15338889.55510253
Depreciation & amortization: 733421.2735339969
Net tangible assets: 29207602.830075547
Owner earnings: 16865907.183115482
Return on net tangible assets (%): 57.74492100991041
Capex to operating income (%): 5.355802098235337
Buffett classification: The Great
Shares outstanding: 104345792
Book value: 29536287.324619256
Debt to equity: 0.16435034719416852
Current ratio: 1.3127343593462268
Quick ratio: 1.2431605236291468
Effective tax rate (%): 26.825144957952496
Interest coverage ratio: 35.65208071288111
COGS to revenue (%): 73.68143541761752
SG&A to revenue (%): 0.32183934276586035
Free cash flow (dilution-adjusted): 13912039.812927209
Retained earnings: 25711656.07386977
Inventory turnover: 22.139316974831406
Receivables turnover: 2.352316578222176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 68.1985636115143
FCF margin (%): 13.237391602008215
Revenue growth (%): 145.95736694584753
Rule of 40 score: 159.19475854785574
Financial ratios for WAAREERTL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 37701146.67940755
Buffett classification: The Gruesome
Shares outstanding: 104345792
Book value: 38001863.35403727
Debt to equity: 0.10196396937812036
Current ratio: 1.323160905410577
Quick ratio: 1.2750409327362948
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WAAREERTL.NS — quarterly report dated 2024-12-31
Total revenue: 42003403.660100244
Gross profit: 9839876.442475813
Operating income: 8194661.382445506
Net income: 6236869.098962583
Capital expenditures: 0
Depreciation & amortization: 189066.32474647393
Owner earnings: 6425935.423709056
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 104345792
Effective tax rate (%): 24.391354197150203
Interest coverage ratio: 21.00510920553348
COGS to revenue (%): 76.5736212186469
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WAAREERTL.NS — quarterly report dated 2025-03-31
Total revenue: 55714274.02384849
Gross profit: 16556301.145662846
Operating income: 14578723.404255318
Net income: 10967208.323591301
Capital expenditures: 0
Depreciation & amortization: 190215.10404489125
Net tangible assets: 52907610.47463175
Owner earnings: 11157423.427636193
Return on net tangible assets (%): 21.088503766364532
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 104345792
Book value: 53185725.97615151
Debt to equity: 0.060165859729416835
Current ratio: 1.3239570653689234
Quick ratio: 1.313432726244006
Effective tax rate (%): 22.61402792048892
Interest coverage ratio: 28.482835803850808
COGS to revenue (%): 70.28355581089342
Retained earnings: 49425216.27308861
Inventory turnover: 51.9249240404291
Receivables turnover: 0.9574761022690288
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.58808688475266
Revenue growth (%): 32.64228412225659
Rule of 40 score: 32.64228412225659
Financial ratios for WAAREERTL.NS — annual report dated 2025-03-31
Total revenue: 186783715.22094926
Gross profit: 41962485.386953466
Operating income: 35600946.92541501
Net income: 26789911.152677108
Capital expenditures: 11855658.171615617
Operating cash flow: 35386626.139817625
Depreciation & amortization: 744949.7311199438
Net tangible assets: 52907610.47463175
Owner earnings: 15679202.712181432
Return on net tangible assets (%): 29.635061140588327
Capex to operating income (%): 33.3015248062181
Buffett classification: The Good
Shares outstanding: 104345792
Book value: 53185725.97615151
Debt to equity: 0.060165859729416835
Current ratio: 1.3239570653689234
Quick ratio: 1.313432726244006
Effective tax rate (%): 23.812549172045916
Interest coverage ratio: 20.5234125433004
COGS to revenue (%): 77.53418421016232
SG&A to revenue (%): 0.25671133725164025
Free cash flow (dilution-adjusted): 23496925.41501052
Retained earnings: 49425216.27308861
Inventory turnover: 192.0383208284244
Receivables turnover: 3.20996632820756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 60.043609574626245
FCF margin (%): 12.579750535112577
Revenue growth (%): 77.72585591368049
Rule of 40 score: 90.30560644879307
Financial ratios for WTN.AX — annual report dated 2021-06-30
Capital expenditures: 0
Net tangible assets: 289370629.3706294
Buffett classification: The Gruesome
Shares outstanding: 296613736
Book value: 289440559.44055945
Debt to equity: 0.3121526938874124
Current ratio: 14.819078947368421
Quick ratio: 13.273026315789474
Retained earnings: 20559440.55944056
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0086.HK — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 2448187660.6683803
Buffett classification: The Gruesome
Stock price: 0.49614395886889456
Trailing EPS: 0.81
P/E ratio: 0.6125234060109809
Shares outstanding: 1955512493
Book value: 3281735218.508998
P/B ratio: 0.29564106952400715
Market cap (USD): 1028026504.8843187
Yahoo trailing P/E: 5.05
Yahoo forward P/E: 4.37
Dividend yield: 0.07
Debt to equity: 0.4579
Current ratio: 2.14
Quick ratio: 2.05
Analyst target mean: 6.40
Analyst target median: 6.40
Analyst consensus upside (%): 1189.9481865284977
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0086.HK — annual report dated 2025-12-31
Total revenue: 454280205.655527
Net income: 233329048.84318766
Capital expenditures: 7776349.614395887
Operating cash flow: 274640102.8277635
Depreciation & amortization: 20771208.22622108
Net tangible assets: 2448187660.6683803
Owner earnings: 246323907.45501286
Return on net tangible assets (%): 10.061479820863237
Buffett classification: The Gruesome
Stock price: 0.49614395886889456
Trailing EPS: 0.81
P/E ratio: 0.6125234060109809
Shares outstanding: 1955512493
Book value: 3281735218.508998
P/B ratio: 0.29564106952400715
Market cap (USD): 1028026504.8843187
Yahoo trailing P/E: 5.05
Yahoo forward P/E: 4.37
Dividend yield: 0.07
Debt to equity: 0.4579
Current ratio: 2.14
Quick ratio: 2.05
Analyst target mean: 6.40
Analyst target median: 6.40
Analyst consensus upside (%): 1189.9481865284977
Effective tax rate (%): 9.700044769437397
COGS to revenue (%): 0
SG&A to revenue (%): 19.166454460572105
Free cash flow (dilution-adjusted): 266555269.92287916
Buyback yield (%): 0
Receivables turnover: 0.26861077543947653
Capitalized R&D asset: 0
FCF margin (%): 58.67639985287044
Revenue growth (%): 50.940457969894645
Rule of 40 score: 109.61685782276508
Financial ratios for 0267.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 91284203821.65605
Buffett classification: The Gruesome
Stock price: 1.2968152866242038
Trailing EPS: 2.33
P/E ratio: 0.5565730843880703
Shares outstanding: 29090262630
Book value: 186089681528.66235
P/B ratio: 0.20272320829721174
Market cap (USD): 44469189821.1465
Yahoo trailing P/E: 5.15
Yahoo forward P/E: 4.77
EV/EBITDA: 5.96
Dividend yield: 0.06
Debt to equity: 2.0774
Current ratio: 1.64
Quick ratio: 0.4
Analyst target mean: 13.90
Analyst target median: 13.50
Analyst consensus upside (%): 971.8565815324165
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0338.HK — quarterly report dated 2026-03-31
Total revenue: 2555955426.917511
Gross profit: 533394934.87698984
Operating income: 81942547.0332851
Net income: 60300289.43560058
Capital expenditures: 129793487.69898698
Net tangible assets: 3307341389.2908826
Owner earnings: -69493198.2633864
Return on net tangible assets (%): -2.101180074376484
Capex to operating income (%): 158.39572041404182
Buffett classification: The Gruesome
Stock price: 0.1568877551020408
Trailing EPS: -0.10
P/E ratio: 2.090398319880541
Shares outstanding: 3213804000
Book value: 3564629377.7134585
P/B ratio: 0.1414471019204201
Market cap (USD): 1754560129.667149
Yahoo forward P/E: 17.06
EV/EBITDA: 8.76
Dividend yield: 0.02
Debt to equity: 0.1273
Current ratio: 1.02
Quick ratio: 0.67
Analyst target mean: 1.47
Analyst target median: 1.41
Analyst consensus upside (%): 836.9756097560975
Effective tax rate (%): 27.57181545435899
COGS to revenue (%): 79.13128964380002
R&D to revenue (%): 0.11714645945917175
SG&A to revenue (%): 2.3979353686733265
Free cash flow (dilution-adjusted): -244301157.74240232
Buyback yield (%): 0
Retained earnings: 807642257.5976845
Inventory turnover: 2.982903452732912
Receivables turnover: 9.54884675750739
Capitalized R&D asset: 3354958.430845565
ROCI (R&D-adjusted, %): 2.081366955561263
Rosenberg metric: 448.3493086067734
FCF margin (%): -9.558114948703553
Revenue growth (%): 7.279372892937659
Rule of 40 score: -2.2787420557658935
Financial ratios for 0436.HK — annual report dated 2025-12-31
Total revenue: 44834704.370179944
Gross profit: 8803727.506426735
Operating income: 516452.44215938303
Net income: -1229948.5861182518
Capital expenditures: 3674293.059125964
Operating cash flow: 7547814.9100257065
Depreciation & amortization: 9327634.961439589
Net tangible assets: 109094473.00771208
Owner earnings: 4423393.3161953725
Capex to operating income (%): 711.4484818317571
Buffett classification: The Gruesome
Stock price: 0.007712082262210797
Trailing EPS: 0.00
Shares outstanding: 3035697018
Book value: 125491516.70951158
P/B ratio: 0.18655878691909653
Market cap (USD): 21460582.00514139
EV/EBITDA: 0.51
Dividend yield: 0.03
Debt to equity: 0.0506
Current ratio: 1.66
Quick ratio: 1.38
Interest coverage ratio: 2.51125
COGS to revenue (%): 80.36403355369912
R&D to revenue (%): 1.4380156759763083
SG&A to revenue (%): 18.21429185755159
Free cash flow (dilution-adjusted): 3328020.565552699
Buyback yield (%): 0
Retained earnings: 39288946.01542416
Inventory turnover: 69.48958849776896
Receivables turnover: 6.866147002086532
Capitalized R&D asset: 1394095.766100059
ROCI (R&D-adjusted, %): 0.33660649686272603
Rosenberg metric: 2.3593291549810114
FCF margin (%): 7.422867201431135
Revenue growth (%): -0.42891398430628835
Rule of 40 score: 6.993953217124846
Financial ratios for 0436.HK — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 109094473.00771208
Buffett classification: The Gruesome
Stock price: 0.007712082262210797
Trailing EPS: 0.00
Shares outstanding: 3035697018
Book value: 125491516.70951158
P/B ratio: 0.18655878691909653
Market cap (USD): 21460582.00514139
EV/EBITDA: 0.51
Dividend yield: 0.03
Debt to equity: 0.0506
Current ratio: 1.66
Quick ratio: 1.38
Buyback yield (%): 0
Retained earnings: 39288946.01542416
Capitalized R&D asset: 0
Rule of 40 score: 0